Morristown, New Jersey– February 5, 2025 – Arxada, a global leader in antimicrobial solutions, announces U.S. Environmental Protection Agency (EPA) registration of Quanticare™ , a revolutionary hard surface disinfection formulation. This versatile product will allow healthcare facilities to reduce disinfection complexity and increase efficiency by replacing several different products with Quanticare™. Not only is it effective against C. diff. and C. auris, but with high surface coverage from each wipe, compatibility with a wide variety of surfaces and materials, and an attractive aesthetic and scent profile2, it can also be used as an everyday hospital, tuberculocidal, and fungicidal disinfectant.
This product is designed for front-line nurses, cleaning staff, and infection preventionists who are leading the fight against healthcare-acquired infections (HAIs) that are estimated to cost the U.S. over $28 billion annually3. These professionals are looking for a single cleaning and disinfecting product that is effective against a wide range of organisms and is easy on surfaces, allowing them to focus on patient care.
“This milestone marks a significant advancement in the field of hard surface disinfection, addressing critical challenges faced by healthcare facilities, dental practices, and in general building disinfection and life science applications. Registered as both a wipe and a ready-to-use (RTU) liquid, QuanticareTM will provide one-step cleaning and disinfecting for outbreaks, and everyday terminal and daily cleaning,” said Lisa Dreilinger, Global Head of Regulatory, Arxada.
Addressing the Challenges in Surface Disinfection
"Healthcare facilities face challenges in ensuring operational efficiency while maintaining disinfection standards. Due to the use of multiple disinfectants, they struggle with gaps in training, dwell time confusion, and inventory complexities. QuanticareTM addresses these challenges by offering high efficacy against a broad spectrum of pathogens along with material compatibility and ease of use. We are committed to collaborating with customers to bring QuanticareTM to market," stated Julie Gallucci, Global VP of Professional Hygiene.
Key Features of Quanticare™
• Effective against Clostridioides difficile in 4 minutes, TB4 and Candida Auris in 1 minute, and bacteria and viruses, including Norovirus, Adenovirus and Poliovirus in just 15 seconds.
• Twice as much surface coverage compared to commonly used tuberculocidal wipes2, making it cost effective for everyday disinfection usage.
• Gentler on key plastics and metals compared to commonly used bleach-based, quat-alcohol-based, and hydrogen peroxide-based wipes, and non-corrosive to stainless steel2.
• Compatible with biodegradable substrates.
• All ingredients are on the EPA Safer Chemical Ingredients List (SCIL)
• Leaves visibly lower residue compared to commonly used bleach-based and hydrogen peroxide-based wipes2, reducing cleaning burden and improving aesthetics.
• Does not require any specific PPE when used as directed.
For more information about Quanticare™ and its benefits, visit https://www.arxada.com/en/hygiene/hygiene-americas/quanticare or contact:
Media contacts:
Tricia Ryan
External Corporate Communications
Arxada
tricia.ryan@arxada.com
Jane Smith
Marketing Communications, Professional Hygiene
Arxada
jane.smith@arxada.com
Footnotes
Use biocides safely. Review and follow all product label and safety instructions. All product information corresponds to Arxada’s knowledge on the subject at the date of publication, but Arxada makes no warranty as to its accuracy or completeness and Arxada assumes no obligation to update it. Product information is intended for use by recipients experienced and knowledgeable in the field, who are capable of and responsible for independently determining the suitability of ingredients for intended uses and to ensure their compliance with applicable law. All trademarks belong to Arxada or its affiliateshttps://www.arxada.com/. © 2025 Arxada.